Related Experiment Video
Updated: May 5, 2026

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
Histo-cytological diagnostic accuracy in lung cancer
A Proietti1, L Boldrini, G Alì
1Department of Surgical, Medical, Molecular Pathology and Critical Area, Division of Pathological Anatomy, University of Pisa, Pisa, Italy.
Accurate lung cancer diagnosis and subtyping are achievable using cytology and biopsy samples, aided by immunohistochemistry. This approach avoids the need for more invasive procedures in most cases.
Area of Science:
- Oncology
- Pathology
- Diagnostic Cytology
Background:
- Accurate lung cancer histotype classification is crucial for targeted therapy selection.
- Traditional classification into small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) is insufficient for modern treatment strategies.
Purpose of the Study:
- To evaluate the diagnostic accuracy and concordance of small biopsy and cytology specimens for lung cancer.
- To assess the utility of immunohistochemistry in determining lung cancer histotype from limited samples.
Main Methods:
- A retrospective review of 941 patients with thoracic lesions from 2009-2011.
- Comparison of pre-operative cytology and biopsy diagnoses with subsequent surgical resection specimens.
- Application of a validated panel of immunohistochemical markers for definitive histotype determination.
Main Results:
- High diagnostic concordance was observed between pre-operative diagnoses (cytology and biopsy) and surgical samples (κ=0.71 and κ=0.61, respectively).
- Moderate concordance was found between cytology and biopsy diagnoses (κ=0.5).
- Immunohistochemistry achieved definitive histotype diagnoses in 92.8% of both cytology and biopsy specimens.
Conclusions:
- Lung cancer diagnosis and subtyping using cytology and biopsy samples are highly feasible and concordant.
- The diagnostic approach utilizing these methods, supported by immunohistochemistry, is effective and can preclude the need for more invasive procedures.
More Related Videos
05:00Author Spotlight: Enhancing Multicolor Fluorescence Localization in Lung Carcinoma Sample
Published on: November 21, 2023
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019